Drug Shortage Report for ANAPROX
| Report ID | 189852 |
| Drug Identification Number | 02162725 |
| Brand name | ANAPROX |
| Common or Proper name | Naproxen sodium tablets USP |
| Company Name | SEARCHLIGHT PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | NAPROXEN SODIUM |
| Strength(s) | 275MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100s |
| ATC code | M01AE |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2023-04-19 |
| Estimated end date | Unknown |
| Actual end date | 2023-05-25 |
| Shortage status | Resolved |
| Updated date | 2023-05-26 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2023-05-26 | French | Compare |
| v6 | 2023-05-25 | French | Compare |
| v5 | 2023-05-25 | English | Compare |
| v4 | 2023-04-20 | English | Compare |
| v3 | 2023-04-19 | French | Compare |
| v2 | 2023-04-19 | English | Compare |
| v1 | 2023-04-19 | English | Compare |
Showing 1 to 7 of 7